First-of-its-Kind Multi-Modal AI Platform Combines Advanced Behavioral Analysis with Claude AI to Accelerate Traumatic Brain ...
Well, after the treatment for transthyretin cardiac amyloidosis has started, our main focus is to look at the progression of ...
Recognized for innovation in Biostatistics, Clinical Data Management, and Real-World Evidence, powered by AI-driven platforms ...
AIM-HI UC was developed and evaluated for exploratory or secondary clinical trial endpoint use. The availability of this algorithm on AISightâ„¢ Clinical Trials creates a powerful, end-to-end solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results